Product Categories
| Country: | China |
|---|---|
| Tel: | 0316-2883536 |
| Mobile: | 19333636468 |
| E-mail: | 573487203@qq.com |
| QQ: | 2885506126 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Enzalutamide impurity B | C8H7BrFNO | 749927-69-3 | Details |
| N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine methyl ester | C13H17FN2O3 | 1332524-01-2 | Details |
| Methyl 2-fluoro-4-((1-methoxy-2-methyl-1-oxopropan-2-yl)amino)benzoate | C13H16FNO4 | 1802242-47-2 | Details |
| Enzalutamide Impurity 7 | C11H12FNO4 | 1332524-02-3 | Details |
| Enzalutamide Impurity 33 | C17H8F6N4S | 1839619-50-9 | Details |
| N-[3-Fluoro-4-[(MethylaMino)carbonyl]phenyl]-2-Methylalanine | C12H15FN2O3 | 1289942-66-0 | Details |
| Enzalutamide Impurity 1 | C22H18F4N4O2S | 1443331-78-9 | Details |
| 2-(2-Methyl-5-tetrazolyl)-5-bromopyridine | C7H6BrN5 | 380380-64-3 | Details |
| Enzalutamide Impurity 5 | C20H14F4N4O2S | 1242137-16-1 | Details |
| Enzalutamide carboxylic acid | C20H13F4N3O3S | 1242137-15-0 | Details |
| Methyl 4-bromo-2-fluorobenzoate | C8H6BrFO2 | 179232-29-2 | Details |
| Enzalutamide | C21H16F4N4O2S | 915087-33-1 | Details |
| Tedizolid Phosphate Impurity R | C10H10BrNO3 | 1252686-47-7 | Details |
| Enzalutamide Impurity12 | C21H15F4N3O3S | 1802242-43-8 | Details |
| OmeprazoleN-oxide | C17H19N3O4S | 176219-04-8 | Details |
| Aztreonam | C13H17N5O8S2 | 78110-38-0 | Details |
| Aztreonam Impurity B | C13H19N5O6S | 102586-36-7 | Details |
| 2-(Hydroxy(4-phenoxyphenyl)methylene)malononitrile | C16H10N2O2 | 330792-68-2 | Details |
| C10H20N2O6S | 80082-50-4 | Details |
| Omeprazole Sulfide | C17H19N3O2S | 73590-85-9 | Details |
| Esomeprazole Impurity 29 | C16H17N3OS | 704910-89-4 | Details |
| Tedizolid Phosphate Impurity G | C17H15FN6O3 | 1431699-67-0 | Details |
| 2-(Methoxy(4-phenoxyphenyl)Methylene)Malononitrile | C17H12N2O2 | 330792-69-3 | Details |
| 5-amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile | C16H12N4O | 330792-70-6 | Details |
| AcotiaMide | C21H30N4O5S | 185106-16-5 | Details |
| 2-(((6-methoxy-1H-benzo[d]imidazol-2-yl)thio)methyl)-3,5- dimethylpyridin-4-ol | C16H17N3O2S | 103876-98-8 | Details |
| 4-methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)thio)methyl)-3,5-dimethylpyridine 1-oxide | C17H19N3O3S | 142885-92-5 | Details |
| Tedizolid Phosphate Impurity 6 | C17H14ClFN6O2 | 1239662-46-4 | Details |
| 2-(Chloromethyl)-3,5-dimethylpyridin-4-ol | C8H10ClNO | 220771-03-9 | Details |
| 5-Methoxy-2-mercaptobenzimidazole | C8H8N2OS | 37052-78-1 | Details |
| Parecoxib Impurity C（Valdecoxib Impurity） | C18H16N2O4S | 198471-06-6 | Details |
| N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)isobutyramide(PalbociclibImpurity) | C20H20N2O4S | 198470-82-5 | Details |
| Parecoxib Impurity | C17H15NO4S | 2749361-92-8 | Details |
| Trelagliptin Impurity | C14H12FN3O3 | 2088203-83-0 | Details |
| 4-(5-Methyl-3-phenylisoxazol-4-yl)-N-((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)benzenesulfonamide(PalbociclibImpurity) | C32H25N3O6S2 | 1373038-60-8 | Details |
| Parecoxib Impurity E | C16H15N3O5S2 | 1373038-59-5 | Details |
| Acotiamide impurity 5 | C12H22N4OS | 206882-15-7 | Details |
| Acotiamide Hydrochloride impurity F | C14H14N2O6S | 185106-01-8 | Details |
| PARECOXIB SODIUM | C19H19N2NaO4S | 198470-85-8 | Details |
| N-Methyl OMeprazole (Mixture of isoMers with the Methylated nitrogens of iMidazole) | C18H21N3O3S | 89352-76-1 | Details |
| Parecoxib Impurity 21 | C18H17NO4S | 1884279-18-8 | Details |
| Acotiamide impurity C | C17H28N2O4 | 1824734-16-8 | Details |
| Omeprazole Impurity 8 | C9H12ClNO2 | 848694-10-0 | Details |
| Aztreonam ethyl ester | C15H21N5O8S2 | 102579-57-7 | Details |
| Trelagliptin Impurity | C15H14FN3O3 | 1938080-43-3 | Details |
| 4-Thiazolecarboxamide, N-[2-[bis(1-methylethyl)amino]ethyl]-2-[(2,4,5-trimethoxybenzoyl)amino]-, hydrochloride (1:1) | C22H33ClN4O5S | 1349810-29-2 | Details |
| Parecoxib Impurity B | C16H13NO4S | 181696-35-5 | Details |
| N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)butyramide(PalbociclibImpurity) | C20H20N2O4S | 198470-91-6 | Details |
| OPEN RING AZTREONAM | C13H19N5O9S2 | 87500-74-1 | Details |
| Valdecoxib | C16H14N2O3S | 181695-72-7 | Details |
| OmeprazolesulfoneN-Oxide | C17H19N3O5S | 158812-85-2 | Details |
| Methyl5-chloro-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate | C6H5ClN2O4 | 91447-90-4 | Details |
| 6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl}-1H-benzimidazole | C17H18N3O4ST | 1810066-05-7 | Details |
| Acotiamide Impurity 10 | C13H12N2O6S | 1809272-85-2 | Details |
| Elagolix Impurity 9 | C40H44F5N3O7 | 2316733-81-8 | Details |
| Benzonitrile, 2-[[6-[(3R)-3-[[(2-cyano-5-fluorophenyl)methyl]amino]-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluoro- | C26H24F2N6O2 | 2412663-46-6 | Details |
| Omeprazole Impurity 1 | C16H17N3O2S | 103877-02-7 | Details |
| Desulfo Aztreonam | C13H17N5O5S | 102579-59-9 | Details |
| Acotiamide Hydrochloride impurity K | C18H24N4O5S | 701197-05-9 | Details |
| 4,5''-Di(desmethyl) Omeprazole Sulfide | C15H15N3O2S | 176219-12-8 | Details |
| 2-[(RS)-[(3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-5- methoxy-1H-benzimidazole | C16H17N3O2S | 110374-16-8 | Details |
| 2-Mercapto-1H-benzo[d]imidazol-5-ol | C7H6N2OS | 92806-98-9 | Details |
| 6-broMo-8-cyclopentyl-5-Methyl-2-(5-(piperazin-1-yl)pyridin-2-ylaMino)pyrido[2,3-d]pyriMidin-7(8H)-one | C22H26BrN7O | 851067-56-6 | Details |
| 2-chloro-N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo [2,3-d]pyrimidin-4-amine | C13H18ClN5 | 1616760-97-4 | Details |
| Argatroban impurity J | C10H8ClNO2S | 1780572-69-1 | Details |
| 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile | C16H20N6O | 477600-75-2 | Details |
| Ethyl2-oxo-2-(pyridin-2-ylamino)acetate(EdoxabanImpurity) | C9H10N2O3 | 41374-72-5 | Details |
| Trelagliptin Impurity 3 | C18H20FN5O2 | 1812193-01-3 | Details |
| 1-(6-Nitropyridin-3-yl)piperazine | C9H12N4O2 | 775288-71-6 | Details |
| 1-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-ethanone | C15H21N5O | 477600-76-3 | Details |
| {4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-methanone | C14H19N5O | 2227199-28-0 | Details |
| Tofacitinib Impurity | C13H19N5 | 477600-74-1 | Details |
| 1H-Imidazole, 1-[2-(ethylsulfinyl)ethyl]-2-methyl-5-nitro- | C8H13N3O3S | 2376335-05-4 | Details |
| Glycine,N-(aminoiminomethyl)-N-methyl-, ethyl ester | C6H13N3O2 | 15366-29-7 | Details |
| 3-[(3R,4R)-3-({2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl}(methyl)amino)-4-methylpiperidin-1-yl]-3-oxopropanenitrile | C16H19ClN6O | 1616761-00-2 | Details |
| (S)-ethyl 2-(((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)amino)-3-methylbutanoate | C21H25N5O2 | 1111394-09-2 | Details |
| Tipiracil Impurity 2 | C9H10ClN3O3 | 2101241-71-6 | Details |
| Isavuconazole Impurity | C8H8N2O2 | 2734004-61-4 | Details |
| N-[[2'-(1-triphenylmethyltetrazole-5-yl)biphenyl-4-yl]methyl]-L-valine ethylester oxalate | 1335138-31-2 | Details |
| Valsartan Desvaleryl Impurity | C19H21N5O2 | 676129-92-3 | Details |
| tert-butyl 4-(6-(6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-ylamino)pyridin-3-yl)piperazine-1-carboxylate | C29H37N7O4 | 1651214-74-2 | Details |
| Argatroban Impurity 6 | C10H8ClNO2S | 94975-84-5 | Details |
| Trelagliptin Impurity 5 | C22H24FN5O5 | 2087874-92-6 | Details |
| Ambroxol EP Impurity B | C14H19Br2ClN2O | 15942-08-2 | Details |
| Valsartan Impurity 3 | C24H28N2O3 | 443093-86-5 | Details |
| Tinidazole Impurity B | C8H13N3O4S | 25459-12-5 | Details |
| Isavuconazole Impurity | C35H37F2N8O6S | 2962831-01-0 | Details |
| Tofacitinib Impurity | C20H25N5 | 477600-73-0 | Details |
| Trelagliptin Impurity S | C18H21FN4O4 | 1917324-15-2 | Details |
| Trelagliptin Impurity X | C18H22FN5O3 | 1938080-44-4 | Details |
| (3R,4R)-1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethylpiperidin-3-amine | C13H18ClN5 | 2504210-32-4 | Details |
| N-[[2'-(1-triphenylmethyltetrazol-5-yl)biphenyl-4-yl]methyl]valine methyl ester oxalate | 1000986-63-9 | Details |
| 1-Boc-4-(6-nitropyridin-3-yl)piperazine | C14H20N4O4 | 571189-16-7 | Details |
| Tofacitinib Impurity | C20H24ClN5 | 923036-25-3 | Details |
| Pyrido[3,2-d]pyrimidin-6(5H)-one, 5-cyclopentyl-8-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]- | C22H27N7O | 2745066-17-3 | Details |
| Valsartan Impurity 25 | C20H23N5O2 | 1111177-24-2 | Details |
| Trelagliptin Impurity 5 | C13H16FN3 | 1971613-57-6 | Details |
| Edoxaban iMpurities | C9H8Cl2N2O3 | 2752546-54-4 | Details |
| N2-(tert-Butoxycarbonyl)-Nw-nitro-D-arginine | C11H21N5O6 | 50913-12-7 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 | ||||